Lumicain
LUMICAIN- aluminum chloride solution
Medical Products Laboratories, Inc.
Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
FOR TOPICAL APPLICATION ONLY
For Granulation Tissue Growth: Allow packing saturated in Lumicain to remain in nail groove for 48 hours; repeat if necessary.
If hemmorrhage is profuse, dress wound with gauze saturated with Lumicain and allow to remain for 24 hours or longer.
CAUTION: Federal Law restricts sale and use to physician or licensed practitioner.
For Rapid Control of Minor Hemorrhage
Each Gram Contains: Aluminium Chloride…………250 mg.
In an aqueous base.
Enter section text here
LUMICAIN aluminium chloride hexahydrate solution | |||||||||||||
| |||||||||||||
| |||||||||||||
| |||||||||||||
| |||||||||||||
|
Labeler — Medical Products Laboratories, Inc. (002290302) |
Registrant — Medical Products Laboratories, Inc. (002290302) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Medical Products Laboratories, Inc. | 002290302 | analysis (10733-412), manufacture (10733-412), label (10733-412), pack (10733-412) |
Revised: 12/2020 Medical Products Laboratories, Inc.
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.